Get the Stockscreener App
1.34
32.67%
0.33
After Hours:
1.36
0.02
+1.49%
Fractyl Health Inc stock is traded at $1.34, with a volume of 74.52M.
It is up +32.67% in the last 24 hours and up +32.67% over the past month.
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.
See More
Previous Close:
$1.01
Open:
$1.195
24h Volume:
74.52M
Relative Volume:
37.79
Market Cap:
$67.39M
Revenue:
-
Net Income/Loss:
$-56.85M
P/E Ratio:
-0.8595
EPS:
-1.559
Net Cash Flow:
-
1W Performance:
+35.56%
1M Performance:
+32.67%
6M Performance:
+5.51%
1Y Performance:
-47.04%
1-Day Range:
$1.06
$1.36
1-Week Range:
$0.96
$1.36
52-Week Range:
$0.825
$3.481
Fractyl Health Inc Stock (GUTS) Company Profile
Name
Fractyl Health Inc
Sector
Industry
Phone
781-902-8800
Address
3 VAN DE GRAAFF DRIVE, BURLINGTON
Compare GUTS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GUTS
Fractyl Health Inc
|
1.34 | 71.53M | 0 | -56.85M | 0 | -1.559 |
|
VRTX
Vertex Pharmaceuticals Inc
|
385.74 | 97.91B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.90 | 58.88B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.40 | 58.93B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
711.62 | 43.52B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
326.06 | 36.11B | 3.81B | -644.79M | -669.77M | -6.24 |
Fractyl Health Inc Stock (GUTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-15-25 | Initiated | H.C. Wainwright | Buy |
| Aug-28-25 | Initiated | Ladenburg Thalmann | Buy |
| Feb-28-24 | Initiated | Evercore ISI | Outperform |
| Feb-27-24 | Initiated | BofA Securities | Buy |
| Feb-27-24 | Initiated | Morgan Stanley | Overweight |
Fractyl Health Inc Stock (GUTS) Latest News
Fractyl Health’s Strategic Moves Boost Investor Confidence - StocksToTrade
GUTS Stock Surges After Promising Clinical Results and Strategic Moves - timothysykes.com
Fractyl Health (GUTS) Is Up 35.6% After Revita Shows Weight Loss Maintained Post-GLP-1 and $60M Raise - Yahoo Finance
Fractyl Health stock gains after pricing of $60M underwritten offering - MSN
Fractyl Health Surges Amid Share Offering, Positive Trial Results - StocksToTrade
Fractyl Health Surges Amid Positive Trial Results and Strategic Developments - timothysykes.com
Latham & Watkins Advises on Fractyl Health’s US$60 Million Underwritten Offering of Common Stock - Latham & Watkins LLP
HC Wainwright & Co. Maintains Fractyl Health (GUTS) Buy Recommendation - Nasdaq
Fractyl Health Inc files for offering of up to 60 million shares of common stockSEC filing - MarketScreener
Fractyl Health (NASDAQ:GUTS) Price Target Lowered to $8.00 at HC Wainwright - MarketBeat
Fractyl Health (GUTS) Stock: Climbs as Company Prices $60M Underwritten Offering at $1.00/Share - parameter.io
Fractyl Health Announces $60M Stock Offering Pricing - MSN
GUTS Stock Rallied About 28% Today – Here’s Why - Stocktwits
Fractyl Health says experimental procedure helps maintain weight-loss in study - whbl.com
Fractyl's Revita shows promise in post-GLP-1 weight maintenance - The Business Journals
Fractyl Health says experimental procedure helps maintain weight loss in study - Reuters
Fractyl Health gains as experimental procedure helps maintain weight-loss in study - TradingView
Fractyl Health Stock Surge: Buying Opportunity? - StocksToTrade
Transcript : Fractyl Health, Inc.Special Call - MarketScreener
Fractyl Health’s Stock Surge: Analyzing Market Dynamics - timothysykes.com
Fractyl Health prices $60 million common stock offering at $1 per share - Investing.com India
GUTS Stock Price and Chart — NASDAQ:GUTS - TradingView
Fractyl’s Revita shows promise in preventing weight regain after GLP-1 use - Investing.com India
Fractyl Health Announces Pricing of $60 Million Underwritten Offering of Common Stock - Nasdaq
Fractyl Health Says Trial Results Support Revita as First Therapy for Post-GLP-1 Weight Maintenance; Shares Rise Pre-Bell - MarketScreener
Fractyl Health's experimental weight-loss procedure shows promise in study - MarketScreener
Fractyl Health announces groundbreaking data from Remain-1 midpoint cohort showing Revita maintained weight loss after GLP-1 discontinuation - MarketScreener
Fractyl Health Announces Groundbreaking Data from REMAIN-1 Midpoint Cohort Showing Revita Maintained Weight Loss After GLP-1 Discontinuation - TradingView
Fractyl Health announces pricing of $60 million underwritten offering of common stock - MarketScreener
$60 Million Stock Offering: Metabolic Therapeutics Company Fractyl Health Raises Capital at $1 Per Share - Stock Titan
Fractyl Health Announces Groundbreaking Data from REMAIN-1 - GlobeNewswire
12.5% Treatment Difference: Fractyl's Revita Procedure Maintains Weight Loss After Stopping Popular GLP-1 Drugs - Stock Titan
Multi factor analysis applied to Fractyl Health Inc.Share Buyback & Fast Gain Stock Tips - newser.com
Real time breakdown of Fractyl Health Inc. stock performanceWeekly Market Report & Long Hold Capital Preservation Tips - newser.com
How to escape a deep drawdown in Fractyl Health Inc.2025 Bull vs Bear & High Accuracy Trade Signal Alerts - newser.com
How to use Fibonacci retracement on Fractyl Health Inc.Quarterly Trade Summary & Real-Time Volume Surge Alerts - newser.com
FOMO Trade: Can Fractyl Health Inc outperform under higher oil pricesGap Up & Reliable Breakout Stock Forecasts - خودرو بانک
What indicators show strength in Fractyl Health Inc.Weekly Earnings Recap & High Win Rate Trade Alerts - newser.com
Fractyl Health (NASDAQ:GUTS) Coverage Initiated by Analysts at HC Wainwright - MarketBeat
Growth Value: Should value investors consider DAWNJuly 2025 PreEarnings & Consistent Profit Alerts - khodrobank.com
How to manage a losing position in Fractyl Health Inc.2025 EndofYear Setup & Growth Focused Stock Pick Reports - newser.com
What machine learning models say about Fractyl Health Inc.Rate Cut & Risk Adjusted Buy/Sell Alerts - newser.com
Will Fractyl Health Inc. see short term momentumTrade Analysis Report & Consistent Profit Focused Trading Strategies - newser.com
Applying chart zones and confluence areas to Fractyl Health Inc.2025 Investor Takeaways & Real-Time Sentiment Analysis - newser.com
What technical models suggest about Fractyl Health Inc.’s comebackJuly 2025 Gainers & Technical Entry and Exit Tips - newser.com
Aug Breakouts: Should I add Fractyl Health Inc stock to my portfolioTrade Exit Summary & Technical Entry and Exit Tips - خودرو بانک
Fractyl Health Appoints New Directors Amid Leadership Changes - MSN
Aug Macro: Is Fractyl Health Inc undervalued by DCF analysisJuly 2025 Volume & Weekly Return Optimization Plans - خودرو بانک
Has Fractyl Health Inc. formed a bullish divergence2025 Technical Overview & Safe Capital Growth Stock Tips - newser.com
FOMO Trade: Can Fractyl Health Inc. expand into new marketsWeekly Loss Report & Daily Technical Stock Forecast Reports - خودرو بانک
Insider Sell: Is Fractyl Health Inc in a long term uptrendMarket Growth Summary & Real-Time Stock Movement Alerts - خودرو بانک
Fractyl Health Inc Stock (GUTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Fractyl Health Inc Stock (GUTS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Barnes Kelly Ann | Director |
Mar 14 '25 |
Buy |
1.30 |
31,000 |
40,210 |
31,000 |
| SCHULMAN AMY W | Director |
Mar 13 '25 |
Buy |
1.17 |
8,550 |
9,964 |
8,550 |
| BRADLEY WILLIAM | Director |
Mar 13 '25 |
Buy |
1.26 |
16,129 |
20,358 |
16,129 |
| Conaway Samuel | Director |
Mar 13 '25 |
Buy |
1.17 |
8,550 |
9,964 |
8,550 |
| Rajagopalan Harith | Chief Executive Officer |
Jan 31 '25 |
Option Exercise |
1.70 |
90,972 |
154,652 |
582,301 |
| Rajagopalan Harith | Chief Executive Officer |
Jan 30 '25 |
Option Exercise |
1.70 |
20,948 |
35,612 |
512,277 |
| Rajagopalan Harith | Chief Executive Officer |
Jan 31 '25 |
Sale |
1.82 |
90,972 |
165,205 |
491,329 |
| Rajagopalan Harith | Chief Executive Officer |
Jan 30 '25 |
Sale |
1.95 |
20,948 |
40,798 |
491,329 |
| Caplan Jay David | President, Chief Product Off. |
Jan 31 '25 |
Option Exercise |
1.70 |
22,346 |
37,988 |
175,890 |
| Caplan Jay David | President, Chief Product Off. |
Jan 30 '25 |
Option Exercise |
1.70 |
21,472 |
36,502 |
175,016 |
3.41%
0.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):